Leukotriene B4 receptor 1 (BLT1) activation by leukotriene B4 (LTB<sub>4</sub>) and E resolvins (RvE1 and RvE2).
Ontology highlight
ABSTRACT: Leukotriene B4 (LTB4) is a lipid inflammatory mediator derived from arachidonic acid (AA). Leukotriene B4 receptor 1 (BLT1), a G protein-coupled receptor (GPCR), is a receptor of LTB4. Nonetheless, the resolution of inflammation is driven by specialized pro-resolving lipid mediators (SPMs) such as resolvins E1 (RvE1) and E2 (RvE2). Both resolvins are derived from omega-3 fatty acid eicosapentaenoic acid (EPA). Here, long-term molecular dynamics simulations (MD) were performed to investigate the activation of the BLT1 receptor using two pro-resolution agonists (RvE1 and RvE2) and an inflammatory agonist (LTB4). We have analyzed the receptor's activation state, electrostatic interactions, and the binding affinity the Molecular Mechanics Poisson-Boltzmann Surfa
SUBMITTER: Nunes VS
PROVIDER: S-EPMC11645204 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA